0000000000721850

AUTHOR

G. Masci

showing 1 related works from this author

Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience

2011

Abstract Aims Triple-negative breast cancers (TNBCs) lack expression of oestrogen, progesterone, and Human Epidermal Growth Factor 2 receptors. The NEMESI study described current Italian treatment practices in patients with operable, early-stage breast cancer (EBC). Patients and methods Retrospective, observational study involving 63 Italian oncology centres. Eligible patients were aged ⩾18 years with EBC (stage I–II) who had undergone surgery, received ⩾1 cycle of adjuvant chemotherapy and/or adjuvant hormonal therapy and attended an oncology centre between 1 January 2008 and 30 June 2008. This subanalysis focused on patients with TNBC. Variables evaluated included: demographic data/clinic…

OncologyCancer ResearchSettore MED/06 - Oncologia MedicaReceptor ErbB-2receptormedicine.medical_treatmentreceptorsGuidelineClinical practicechemotherapyAntineoplastic Combined Chemotherapy ProtocolsestrogenMedicineStage (cooking)Triple-negative breast cancerAdjuvant therapy Clinical practice Guidelines Italy National register Triple-negative breast cancer --------------------------------------------------------------------------------Middle AgedCombined Modality TherapyReceptors EstrogenItalyOncologyChemotherapy AdjuvantHormonal therapyFemaleReceptors Progesteronemedicine.medical_specialtyNational registerBreast NeoplasmsprogesteroneGuidelinesAdjuvant therapyBreast canceradjuvantTriple-negative breast canceradjuvant therapy; clinical practice; guidelines; italy; national register; triple-negative breast cancer; aged; antineoplastic combined chemotherapy protocols; breast neoplasms; chemotherapy adjuvant; combined modality therapy; female; humans; italy; middle aged; radiotherapy adjuvant; receptor erbb-2; receptors estrogen; receptors progesterone; retrospective studiesInternal medicineAdjuvant therapyHumansradiotherapyAgedRetrospective StudiesChemotherapybusiness.industryTriple-negative breast cancer --------------------------------------------------------------------------------medicine.diseaseRadiation therapyAged Antineoplastic Combined Chemotherapy Protocols; therapeutic use Breast NeoplasmsRadiotherapy AdjuvantObservational studybusinesserbb-2
researchProduct